CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.8493
-0.0367 (-4.14%)
Sep 17, 2026, 10:51 AM EDT - Market open
CytoMed Therapeutics Employees
CytoMed Therapeutics had 42 employees as of December 31, 2025. The number of employees decreased by 1 or -2.33% compared to the previous year.
Employees
42
Change (1Y)
-1
Growth (1Y)
-2.33%
Revenue / Employee
$15,935
Profits / Employee
-$73,683
Market Cap
10.05M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 42 | -1 | -2.33% |
| Dec 31, 2024 | 43 | 9 | 26.47% |
| Dec 31, 2023 | 34 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Senti Biosciences Holdings | 39 |
| Lunai Bioworks | 29 |
| IN8bio | 18 |
| Theriva Biologics | 16 |
| FibroBiologics | 15 |
| Ensysce Biosciences | 10 |
| Aprea Therapeutics | 8 |
| Immuron | 7 |
GDTC News
- 5 months ago - CytoMed Therapeutics Annual report: H2 2025 - Filings
- 7 months ago - Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress - TheFly
- 8 months ago - Cytomed sees ‘enough resources’ to continue activites for ‘at least a year’ - TheFly
- 9 months ago - Cytomed Therapeutics enters into MoU with UMMC - TheFly
- 10 months ago - CytoMed completes acquisition of T cell technology of TC BioPharm - TheFly
- 10 months ago - Cytomed Therapeutics secures investment for subsidiary LongevityBank - TheFly
- 11 months ago - Cytomed Therapeutics chairman Peter Choo increases holdings to 21.95% - TheFly
- 11 months ago - Cytomed announces cash bid for potential acquisition of TC BioPharm - TheFly